Nowe cytochromy P 450 jako biomarkery i potencjalne cele oddziaływania w chemioprewencji i terapii nowotworów New cytochrome P 450 isoforms as cancer biomarkers and targets for chemopreventive and chemotherapeutic agents

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of CYP1A1, CYP1A2 and CYP1B1 Expression by Cabbage Juices and Indoles in Human Breast Cell Lines

  2012cited by this paper
• The roles of cytochrome P450 enzymes in prostate cancer development and treatment.

  2012cited by this paper
• CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

  2011cited by this paper
• Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology

  2011cited by this paper
• Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs

  2011cited by this paper
• Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation.

  2010cited by this paper
• Association of CYP1B1 Polymorphisms with Breast Cancer: A Case-Control Study in the Han Population in Ningxia Hui Autonomous Region, P. R. China

  2010cited by this paper
• Diminished Carcinogen Detoxification Is a Novel Mechanism for Hypoxia-inducible Factor 1-mediated Genetic Instability*

  2010cited by this paper
• Profiling the expression of cytochrome P450 in breast cancer

  2010cited by this paper
• Characterization of a new cytochrome P450 enzyme, CYP2S1, in rats: its regulation by aryl hydrocarbon receptor agonists.

  2010cited by this paper
• Colorectal Cancer-Specific Cytochrome P450 2W1: Intracellular Localization, Glycosylation, and Catalytic Activity

  2010cited by this paper
• Efficient Hypoxic Activation of the Anticancer Agent AQ4N by CYP2S1 and CYP2W1

  2010cited by this paper
• Functional Characterization of Human Cytochrome P450 2S1 Using a Synthetic Gene-Expressed Protein in Escherichia coli

  2009cited by this paper
• [Cytochrome P450 isoenzymes in metabolism of endo- and exogenic compounds].

  2009cited by this paper
• Nutrition and the Prevention and Treatment of Cancer: Association of Cytochrome P450 CYP1B1 With the Role of Fruit and Fruit Extracts

  2009cited by this paper
• Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis.

  2009cited by this paper
• Durable complete response to frontline docetaxel in an advanced prostate cancer patient with favourable CYP1B1 isoforms: suggestion for changing paradigms?

  2008cited by this paper
• The effect of initiating doses of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene on the expression of PAH activating enzymes and its modulation by plant phenols.

  2008cited by this paper
• Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel

  2008cited by this paper
• A Novel Promoter Element Containing Multiple Overlapping Xenobiotic and Hypoxia Response Elements Mediates Induction of Cytochrome P4502S1 by Both Dioxin and Hypoxia*

  2007cited by this paper
• Expression of Xenobiotic Metabolizing Enzymes in Different Lung Compartments of Smokers and Nonsmokers

  2006cited by this paper
• Recombinant Enzymes Overexpressed in Bacteria Show Broad Catalytic Specificity of Human Cytochrome P450 2W1 and Limited Activity of Human Cytochrome P450 2S1

  2006cited by this paper
• Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention

  2006cited by this paper
• Enzymatic properties of human CYP2W1 expressed in Escherichia coli.

  2006cited by this paper
• Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.

  2006cited by this paper
• Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer

  2006cited by this paper
• Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women

  2006cited by this paper
• Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis

  2005cited by this paper
• Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis

  2005cited by this paper
• Novel extrahepatic cytochrome P450s.

  2005cited by this paper
• Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues.

  2005cited by this paper
• Profiling Cytochrome P450 Expression in Ovarian Cancer: Identification of Prognostic Markers

  2005cited by this paper
• CYP2S1: a short review.

  2005cited by this paper
• Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

  2004cited by this paper
• Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase.

  2004cited by this paper
• Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.

  2004cited by this paper
• Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1.

  2004cited by this paper
• Cytochrome P450 enzymes and tumor therapy.

  2004cited by this paper
• CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes ω- and (ω-1)-Hydroxylation of Fatty Acids*

  2004cited by this paper
• Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.

  2003cited by this paper
• De-orphanization of Cytochrome P450 2R1

  2003cited by this paper
• Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases.

  2003cited by this paper
• Identification of a novel dioxin-inducible cytochrome P450.

  2002cited by this paper
• Lung carcinogenesis: Resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells

  2001cited by this paper
• Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.

  2001cited by this paper
• Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1).

  2001cited by this paper
• Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.

  2001cited by this paper
• Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer.

  2000cited by this paper
• Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model

  2000cited by this paper
• Cytochrome P450-based cancer gene therapy: recent advances and future prospects.

  1999cited by this paper
• Immunohistochemical Localization of Cytochrome P450 CYP1B1 in Breast Cancer with Monoclonal Antibodies Specific for CYP1B1

  1999cited by this paper
• Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.

  1998cited by this paper
• Tumor-specific expression of cytochrome P450 CYP1B1.

  1997cited by this paper
• Isolation and Characterization of the Human Cytochrome P450 CYP1B1 Gene*

  1996cited by this paper
• 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.

  1996cited by this paper

• No citing papers are available for this paper.